News Archives

SPR Therapeutics Announces 10,000th SPRINT PNS Procedure for Patients Suffering from Life-Altering Pain

May 11, 2022

– Adoption of SPRINT® PNS System Doubled Within the Last Year – Cleveland, Ohio – May 12, 2022- Cleveland based medical device company SPR Therapeutics today announced a key milestone …

Category: News

Real-world Study of SPRINT 60-day Peripheral Nerve Stimulation (PNS) Corroborates Published Clinical Study Results

May 6, 2022

Cleveland, Ohio – May 6, 2022 – SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management of …

Category: News

How May Temporary 60-Day PNS Treatment Improve Identification of Delayed Responders and Non-Responders to Neurostimulation?

April 28, 2022

Peripheral nerve stimulation (PNS) has broad applications for pain relief and has been successfully used to treat myriad types of pain. Current conventional neurostimulation systems for pain relief …

Category: NewsTag: 60-day percutaneous PNS, PNS, SPRINT PNS, SPRINT PNS System

The PNS Trifecta: All Three SPRINT® PNS System Abstracts Submitted to ASRA 2021 Pain Medicine Meeting Receive President’s Choice Award

November 18, 2021

Studies Assessed Medial Branch PNS in Chronic Back Pain, Real World Evidence for PNS and Identification of Delayed Responders During 60-Day PNS Treatment Cleveland, Ohio- November 18, 2021 – …

Category: News

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SPR Therapeutics Announces 10,000th SPRINT PNS Procedure for Patients Suffering from Life-Altering Pain

Real-world Study of SPRINT 60-day Peripheral Nerve Stimulation (PNS) Corroborates Published Clinical Study Results

How May Temporary 60-Day PNS Treatment Improve Identification of Delayed Responders and Non-Responders to Neurostimulation?

The PNS Trifecta: All Three SPRINT® PNS System Abstracts Submitted to ASRA 2021 Pain Medicine Meeting Receive President’s Choice Award

SPR® Therapeutics Named #1 on Crain’s Cleveland Business Fast 50 list

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List

SPR Therapeutics Founder and CEO Maria Bennett on managing pain with nerve stimulation, not drugs: Women Who Lead